• metavia reports additional positive top-line results from the mad part 2 of its phase 1 study of da-1726, a novel 31 ratio glp-1 a... marketscreener.com Tue, 22 Apr 2025 12:33:08 GMT
• metavia’s (mtva) buy rating reiterated at hc wainwright Defense World Sat, 19 Apr 2025 07:00:00 GMT
• MetaVia’s obesity drug cuts body weight by 6.3% in 26 days in phase 1 koreabiomed.com Wed, 16 Apr 2025 07:00:00 GMT
• Metavia Announces Positive Top-Line Data From The 4-Week Phase 1 Mad Trial Of Da-1726 marketscreener.com Tue, 15 Apr 2025 07:00:00 GMT
• metavia reports 'positive' results for obesity treatment in part 2 of phase 1 trial marketscreener.com Tue, 15 Apr 2025 07:00:00 GMT
• metavia inc. reports progress in cardiometabolic drug development MSN Mon, 24 Mar 2025 23:44:06 GMT
• fy2029 earnings forecast for metavia issued by hc wainwright Defense World Mon, 24 Mar 2025 07:00:00 GMT
• hc wainwright reaffirms “buy” rating for metavia (nasdaq:mtva) Defense World Sun, 23 Mar 2025 07:00:00 GMT
• metavia inc. reports progress in cardiometabolic drug development MSN Sat, 22 Mar 2025 19:06:20 GMT
• metavia inc (mtva) reports q4 eps of -0.59, revenue at $0 millio GuruFocus Sat, 22 Mar 2025 08:35:26 GMT
• metavia inc. reports progress in cardiometabolic drug development TipRanks Fri, 21 Mar 2025 07:00:00 GMT
• MetaVia Reports Year End 2024 Financial Results and Provides Corporate Update PR Newswire Thu, 20 Mar 2025 07:00:00 GMT
• metavia (mtva) expected to announce quarterly earnings on thursday Defense World Thu, 20 Mar 2025 07:00:00 GMT
• neurobo pharmaceuticals (nrbo) to release quarterly earnings on thursday Defense World Thu, 20 Mar 2025 07:00:00 GMT
• neurobo says da-1241, wegovy combo shows potential in treating mash MSN Wed, 19 Mar 2025 12:36:25 GMT
• neurobo pharmaceuticals (nasdaq:nrbo) stock price up 1.5% – still a buy? Defense World Tue, 18 Feb 2025 08:00:00 GMT
• financial survey: neurobo pharmaceuticals (nasdaq:nrbo) & northwest biotherapeutics (otcmkts:nwbo) Defense World Wed, 29 Jan 2025 08:00:00 GMT
• neurobo pharmaceuticals (nasdaq:nrbo) stock price up 2.9% – here’s why Defense World Wed, 22 Jan 2025 08:00:00 GMT
• neurobo pharmaceuticals : statement of changes in beneficial ownership - form 4 Marketscreener.com Tue, 14 Jan 2025 03:16:10 GMT
• non-alcoholic steatohepatitis market to show remarkable growth trends from 2024 to 2034, delveinsight reports | madrigal pharmac, ... The Globe and Mail Wed, 08 Jan 2025 22:28:25 GMT
• what is hc wainwright’s estimate for metavia q4 earnings? Defense World Thu, 02 Jan 2025 08:00:00 GMT
• analysts offer predictions for metavia fy2024 earnings Defense World Wed, 01 Jan 2025 08:00:00 GMT
• neurobo pharmaceuticals (nasdaq:nrbo) trading down 2.8% – what’s next? Defense World Tue, 31 Dec 2024 08:00:00 GMT
• metavia (nasdaq:mtva) now covered by analysts at hc wainwright Defense World Tue, 31 Dec 2024 08:00:00 GMT
• metavia shares debut with buy rating as da-1726 shows preclinical weight-loss results Investing.com Mon, 30 Dec 2024 08:00:00 GMT
• mtva stock touches 52-week low at $2 amid market challenges Investing.com Australia Thu, 19 Dec 2024 01:21:08 GMT
• MetaVia reports positive DA-1241 trial results for MASH Investing.com Wed, 18 Dec 2024 08:00:00 GMT
• mtva stock touches 52-week low at $2 amid market challenges Investing.com Wed, 18 Dec 2024 08:00:00 GMT
• neurobo pharmaceuticals : reports third quarter 2021 financial results - form 8-k Marketscreener.com Tue, 17 Dec 2024 15:50:23 GMT
• reviewing intercure (nasdaq:incr) & neurobo pharmaceuticals (nasdaq:nrbo) Defense World Sun, 15 Dec 2024 08:00:00 GMT
• diabetic nephropathy market expected to experience major growth by 2034, according to delveinsight | astrazeneca, neurobo pharma, ... Barchart Tue, 10 Dec 2024 08:00:00 GMT
• mtva stock touches 52-week low at $2.04 amid market challenges Investing.com India Sat, 07 Dec 2024 01:53:17 GMT
• mtva stock touches 52-week low at $2.04 amid market challenges Investing.com Fri, 06 Dec 2024 08:00:00 GMT
• neurobo pharmaceuticals, inc. announced that it expects to receive $10 million in funding Marketscreener.com Wed, 04 Dec 2024 13:08:14 GMT
• neurobo pharmaceuticals, inc. announced that it expects to receive $15 million in funding from dong-a st co., ltd. Marketscreener.com Mon, 02 Dec 2024 17:26:47 GMT
• neurobo pharmaceuticals, inc. appoints d. gordon strickland to its board of directors Marketscreener.com Sat, 30 Nov 2024 08:52:48 GMT
• neurobo pharmaceuticals, inc. announces unaudited consolidated earnings results for the first quarter ended march 31, 2021 Marketscreener.com Sat, 30 Nov 2024 07:15:05 GMT
• neurobo pharmaceuticals appoints hyung heon kim as chief executive officer and president Marketscreener.com Sat, 30 Nov 2024 07:11:00 GMT
• neurobo pharmaceuticals, inc. completes enrollment of part 1 of its phase 2a clinical trial evaluating da-1241 for the treatment o... Marketscreener.com Sat, 30 Nov 2024 06:54:21 GMT
• neurobo to participate in the h.c. wainwright 26th annual global investment conference Marketscreener.com Sat, 30 Nov 2024 06:26:01 GMT
• neurobo pharmaceuticals announces executive changes Marketscreener.com Sat, 30 Nov 2024 06:23:31 GMT
• neurobo pharmaceuticals, inc. decides to discontinue its clinical development of ana001 (niclosamide) and clinical development of ... Marketscreener.com Sat, 30 Nov 2024 06:22:49 GMT
• neurobo pharmaceuticals, inc. receives first site irb approval for its phase 2a clinical trial evaluating da-1241 for the treatmen... Marketscreener.com Sat, 30 Nov 2024 06:20:49 GMT
• neurobo pharmaceuticals, inc. announces management changes Marketscreener.com Sat, 30 Nov 2024 06:19:13 GMT
• neurobo pharmaceuticals, inc. announces ceo changes Marketscreener.com Sat, 30 Nov 2024 06:17:35 GMT
• neurobo pharmaceuticals, inc. announces the appointment of current board member, hyung heon ("h.h.") kim as the company's presiden... Marketscreener.com Sat, 30 Nov 2024 06:08:30 GMT
• neurobo pharmaceuticals, inc. announces board changes Marketscreener.com Sat, 30 Nov 2024 06:00:58 GMT
• neurobo pharmaceuticals announces management changes Marketscreener.com Sat, 30 Nov 2024 05:59:33 GMT
• neurobo pharmaceuticals, inc. announces exclusive license agreement with mthera pharma co., ltd. for nb-01 Marketscreener.com Sat, 30 Nov 2024 05:54:29 GMT
• neurobo pharmaceuticals, inc. elects hyung heon kim and andrew i. koven to board of directors Marketscreener.com Sat, 30 Nov 2024 05:50:18 GMT
• neurobo pharmaceuticals, inc. announces executive changes Marketscreener.com Sat, 30 Nov 2024 05:47:44 GMT
• neurobo pharmaceuticals, inc. announces joint research agreement, together with dong-a st and immunoforge to develop a long-acting... Marketscreener.com Sat, 30 Nov 2024 05:46:57 GMT
• neurobo pharmaceuticals, inc. reports earnings results for the third quarter and nine months ended september 30, 2024 Marketscreener.com Sat, 30 Nov 2024 05:39:09 GMT
• neurobo pharmaceuticals reveals promising therapeutic developments TipRanks Fri, 29 Nov 2024 08:00:00 GMT
• neurobo pharmaceuticals announces strategic realignment ahead of important clinical milestones with name change to metavia - refle... Yahoo Finance Mon, 18 Nov 2024 08:00:00 GMT
• neurobo pharma rebrands as metavia, advances $70m cardiometabolic pipeline StockTitan Mon, 18 Nov 2024 08:00:00 GMT
• neurobo rebrands to metavia, changes nasdaq ticker to mtva Investing.com Mon, 18 Nov 2024 08:00:00 GMT
• armistice capital, llc acquires shares in neurobo pharmaceuticals inc GuruFocus.com Fri, 15 Nov 2024 04:47:59 GMT
• neurobo pharmaceuticals to participate in investor conferences in november cnhinews.com Wed, 13 Nov 2024 08:00:00 GMT
• nrbo: topline results for phase 2a trial of da-1241 in mash expected in december 2024 Yahoo Finance Wed, 13 Nov 2024 08:00:00 GMT
• neurobo pharmaceuticals to present at the november 21st virtual investor summit microcap event Financial Content Mon, 11 Nov 2024 08:00:00 GMT
• neurobo pharmaceuticals reports third quarter 2024 financial results and provides corporate update citybiz Thu, 07 Nov 2024 19:32:47 GMT
• neurobo pharmaceuticals completes final dosing in us phase 2 trial for mash treatment KBR Tue, 05 Nov 2024 08:00:00 GMT
• neurobo pharmaceuticals completes phase 2a trial for mash drug TipRanks Mon, 04 Nov 2024 08:00:00 GMT
• diabetic nephropathy market to reach new heights in growth by 2034, delveinsight predicts | astrazeneca, neurobo pharma, don-a st,... Barchart Tue, 22 Oct 2024 07:00:00 GMT
• nrbo stock touches 52-week low at $2.55 amid market challenges Investing.com Thu, 10 Oct 2024 07:00:00 GMT
• neurobo pharmaceuticals unveils updated corporate presentation TipRanks Mon, 07 Oct 2024 11:32:29 GMT
• neurobo confirms safety of obesity drug da-1726 in phase 1 study KBR Fri, 04 Oct 2024 07:00:00 GMT
• here's why we're a bit worried about neurobo pharmaceuticals' (nasdaq:nrbo) cash burn situation Simply Wall St Thu, 03 Oct 2024 07:00:00 GMT
• nrbo stock touches 52-week low at $2.9 amid market challenges by investing.com Investing.com South Africa Wed, 02 Oct 2024 03:39:28 GMT
• NRBO: Positive SAD Part 1 Data; MAD Part 2 Results Expected in 1Q25… Zacks Small Cap Research Tue, 01 Oct 2024 07:00:00 GMT
• nrbo - neurobo pharmaceuticals inc latest stock news & market updates Stock Titan Tue, 01 Oct 2024 07:00:00 GMT
• neurobo pharmaceuticals to participate in investor conferences in october Finansavisen Tue, 01 Oct 2024 07:00:00 GMT
• nrbo stock touches 52-week low at $2.9 amid market challenges Investing.com India Tue, 01 Oct 2024 07:00:00 GMT
• neurobo reports positive early trial results for obesity drug by investing.com Investing.com South Africa Tue, 01 Oct 2024 03:00:10 GMT
• neurobo pharmaceuticals announces data from sad part 1 of trial of da-1726 TipRanks Mon, 30 Sep 2024 12:30:41 GMT
• nrbo: positive sad part 1 data; mad part 2 results expected in 1q25… MSN Mon, 30 Sep 2024 07:00:00 GMT
• we're a little worried about neurobo pharmaceuticals' (nasdaq:nrbo) cash burn rate Yahoo Finance Mon, 30 Sep 2024 07:00:00 GMT
• neurobo reports positive early trial results for obesity drug by investing.com Investing.com Australia Mon, 30 Sep 2024 07:00:00 GMT
• affinity asset advisors llc invests $432,000 in neurobo pharmaceuticals, inc. (nasdaq:nrbo) Defense World Wed, 25 Sep 2024 13:21:04 GMT
• neurobo shareholders approve significant stock issuance Investing.com India Fri, 20 Sep 2024 12:21:21 GMT
• dong-a st executives sell neurobo pharmaceuticals shares worth over $1,500 Investing.com Fri, 20 Sep 2024 07:00:00 GMT
• neurobo to participate in the h.c. wainwright 26th annual global investment conference Finansavisen Tue, 03 Sep 2024 07:00:00 GMT
• nrbo: data from part 1 of phase 1 trial of da-1726 in 3q24… Yahoo Finance Wed, 21 Aug 2024 07:00:00 GMT
• neurobo pharmaceuticals completes patient enrollment for phase 1 trial for antiobesity drug The Korea Herald Fri, 16 Aug 2024 07:00:00 GMT
• neurobo pharmaceuticals inc. filed sec form 8-k: results of operations and financial condition, financial statements and exhibits Quantisnow Wed, 14 Aug 2024 12:01:18 GMT
• neurobo concludes subject enrolment in sad portion of obesity treatment trial Clinical Trials Arena Wed, 14 Aug 2024 07:00:00 GMT
• neurobo pharmaceuticals reports second quarter 2024 financial results and provides corporate update The Eastern Progress Online Wed, 14 Aug 2024 07:00:00 GMT
• neurobo pharmaceuticals reports q2 eps ($1.85), consensus ($1.12) TipRanks Wed, 14 Aug 2024 07:00:00 GMT
• neurobo pharmaceuticals completes enrollment of the sad part 1 of its phase 1 clinical trial evaluating da-1726 for the treatment ... Finansavisen Tue, 13 Aug 2024 07:00:00 GMT
• neurobo completes first phase 1 enrollment for obesity drug trial TipRanks Tue, 13 Aug 2024 07:00:00 GMT
• neurobo pharmaceuticals completes enrollment in phase 1 trial of da-1726 TipRanks Tue, 13 Aug 2024 07:00:00 GMT
• dong-a st and its subsidiary to codevelop long-acting obesity drug with immunoforge KBR Thu, 08 Aug 2024 07:00:00 GMT
• obesity clinical trial pipeline appears robust with 80+ key pharma companies actively working in the therapeutics segment | delvei... India Shorts Tue, 06 Aug 2024 16:30:00 GMT
• neurobo pharmaceuticals signs research agreement for obesity treatment TipRanks Tue, 06 Aug 2024 12:00:00 GMT
• neurobo pharmaceuticals announces joint research agreement, together with dong-a st and immunoforge to develop a long-acting once-... Finansavisen Tue, 06 Aug 2024 07:00:00 GMT
• neurobo partners for long-acting obesity treatment Investing.com India Tue, 06 Aug 2024 07:00:00 GMT
• neurobo partners for monthly dual-action diabetes drug development TipRanks Tue, 06 Aug 2024 07:00:00 GMT
• NeuroBo licenses NB-01 to MThera Pharma for diabetic neuropathy treatment koreabiomed.com Wed, 31 Jul 2024 07:00:00 GMT
• NeuroBo Signs Exclusive License Agreement with MTHERA for NB-01 Contract Pharma Tue, 30 Jul 2024 07:00:00 GMT
• neurobo licenses diabetic neuropathy drug to mthera pharma Investing.com Tue, 30 Jul 2024 07:00:00 GMT
• neurobo pharmaceuticals announces license agreement with mthera pharma TipRanks Tue, 30 Jul 2024 07:00:00 GMT
• dong-a st’s q2 operating profit falls 19% on year due to smaller prescription drugs sales KBR Fri, 26 Jul 2024 07:00:00 GMT
• neurobo pharmaceuticals (nasdaq:nrbo) shares down 3.4% Defense World Wed, 17 Jul 2024 07:00:00 GMT
• bix 2024: from graveyard to breakthrough, mash candidates on rise BioWorld Online Tue, 16 Jul 2024 16:00:00 GMT
• neurobo pharmaceuticals doses first patient in mad part 2 of da-1726 trial TipRanks Tue, 16 Jul 2024 15:17:39 GMT
• donga st, subsidiary mash and obesity drug clinical results expected this year 코메디닷컴 Tue, 16 Jul 2024 07:00:00 GMT
• neurobo pharmaceuticals releases corporate presentation update TipRanks Tue, 16 Jul 2024 07:00:00 GMT
• bix 2024: from graveyard to breakthrough, mash candidates on rise BioWorld Online Thu, 11 Jul 2024 07:00:00 GMT
• hanmi pharm, neurobo unveil next-gen obesity drugs at bioplus-interphex korea 2024 KBR Thu, 11 Jul 2024 07:00:00 GMT
• neurobo pharmaceuticals to present at the emerging growth conference in july Finansavisen Thu, 11 Jul 2024 07:00:00 GMT
• amendment: large owner dong-a st co., ltd bought $10,000,003 worth of shares (2,544,530 units at $3.93), increasing direct ownersh... Quantisnow Wed, 10 Jul 2024 15:17:10 GMT
• [top trends] homozygous familial hypercholesterolemia epidemiology market | neurobo pharmaceuticals, aegerion pharmaceutical, arro... Economica Mon, 08 Jul 2024 09:23:07 GMT
• nrbo: da-1726 shows superiority to survodutide in pre-clinical models… Yahoo Finance Mon, 01 Jul 2024 07:00:00 GMT
• huge insider buying at a warren buffett pick and 5 other stocks 24/7 Wall St. Sun, 30 Jun 2024 07:00:00 GMT
• r&d focus sets dong-a st apart in biosimilars The Korea JoongAng Daily Fri, 28 Jun 2024 07:00:00 GMT
• neurobo pharmaceuticals (nasdaq:nrbo) versus jazz pharmaceuticals (nasdaq:jazz) financial contrast Defense World Fri, 28 Jun 2024 07:00:00 GMT
• neurobo pharmaceuticals, inc. appoints pharmaceutical industry executive, mark a. glickman, to its board of directors The Globe and Mail Thu, 27 Jun 2024 11:49:11 GMT
• NeuroBo doses first subject in Part 2 of Phase I obesity treatment trial Clinical Trials Arena Thu, 27 Jun 2024 07:00:00 GMT
• neurobo begins dosing patients for obesity drug’s us phase 1 trial KBR Thu, 27 Jun 2024 07:00:00 GMT
• neurobo starts obesity drug trial ahead of schedule Investing.com India Thu, 27 Jun 2024 07:00:00 GMT
• neurobo pharmaceuticals, inc. (nasdaq:nrbo) major shareholder st co. ltd dong-a acquires 2544530 shares Defense World Thu, 27 Jun 2024 05:04:32 GMT
• evaxion biotech advances in personalized cancer vaccine by investing.com Investing.com India Wed, 26 Jun 2024 19:11:06 GMT
• chipotle shares maintain buy rating, price target adjusted on recent stock split by investing.com Investing.com India Wed, 26 Jun 2024 18:53:13 GMT
• chipotle shares start trading post 50-for-1 stock split by investing.com Investing.com India Wed, 26 Jun 2024 18:53:12 GMT
• draftkings stock target cut, maintains buy rating by investing.com Investing.com Wed, 26 Jun 2024 18:43:55 GMT
NeuroBo Pharmaceuticals, Inc.(NASDAQ:NRBO) 
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for coronavirus, neurodegenerative, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which has completed Phase 2 clinical trial to treat patients with mode...
Website: http://www.neurobopharma.com
Founded: 2017
CEO: Richard Kang
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends